Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | METAP2 | P50579 | 1/20 | 0.55 |
| ▸ | CCR1 | P32246 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | CCR5 | P51681 | 1/20 | 0.54 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinoline SCHEMBL28875612 | 0.84 | PDE10A (0.53) | MCHR1MEN1KMT2ARAB9APDE10A | |
| SCHEMBL20561242 | 0.82 | MEN1 (0.54) | MCHR1MEN1KMT2AMETAP2CCR1 | |
| SCHEMBL2092748 | 0.82 | MEN1 (0.54) | MCHR1MEN1KMT2AMETAP2CCR1 | |
| SCHEMBL19603062 | 0.82 | MCHR1 (0.67) | MCHR1KMT2ARAB9APDE10AKDM4E | |
| SCHEMBL24375928 | 0.81 | MEN1 (0.53) | MCHR1MEN1KMT2AMETAP2CCR1 | |
| SCHEMBL27576259 | 0.81 | MEN1 (0.55) | MCHR1MEN1KMT2AMETAP2CCR1 | |
| SCHEMBL10029548 | 0.81 | MEN1 (0.65) | MCHR1MEN1KMT2AMETAP2CCR1 | |
| SCHEMBL28886096 | 0.81 | CCR1 (0.56) | MCHR1MEN1KMT2AMETAP2CCR1 | |
| SCHEMBL15648746 | 0.80 | MCHR1 (0.65) | MCHR1MEN1KMT2ARAB9APDE10A | |
| SCHEMBL873240 | 0.80 | MCHR1 (0.70) | MCHR1PDE10AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112979619-A | Method for catalyzing dehydrogenation coupling reaction of nitrogen heteroaromatic ring compound and cyclic ether by using Bronsted acid | 青岛职业技术学院 | 2021-06-18 | — | — | CN | claimed |
| CN-110075900-A | The mesoporous carbon-silica catalyst material and preparation method and application of supported palladium | 上海师范大学 | 2019-08-02 | — | — | CN | claimed |
| EP-2265677-B1 | CORROSION DETECTION PRODUCT AND METHOD | BATTELLE MEMORIAL INSTITUTE (US) | 2019-05-15 | — | — | EP | claimed |
| CN-104447539-B | A kind of two grades, the synthetic method of three-level aromatic amides | 湖南大学 | 2017-09-15 | — | — | CN | claimed |
| US-9321730-B2 | Method of making and administering quinoline derivatives as anti-cancer agents | THE HONG KONG POLYTECHNIC UNIVERSITY (HK) | 2016-04-26 | — | — | US | claimed |
| CN-105418605-A | Improved preparation method for nitrogenous tricyclic dopamine D3 acceptor ligand | UNIV SOUTHEAST | 2016-03-23 | — | — | CN | claimed |
| CN-104447540-A | Synthetic method of primary aryl amide compounds | UNIV HUNAN | 2015-03-25 | — | — | CN | claimed |
| CN-104447539-A | Method for synthesizing binary and ternary aryl amide compounds | UNIV HUNAN | 2015-03-25 | — | — | CN | claimed |
| CN-1150168-C | Amphiphili 8-hydroxyquinoline complex, its preparing process and its application in electroluminescence | 暨南大学 | 2004-05-19 | — | — | CN | claimed |
| CN-1282735-A | Amphiphili 8-hydroxyquinoline complex, its preparing process and its application in electroluminescence | UNIV JINAN (CN) | 2001-02-07 | — | — | CN | claimed |
| CN-116283759-B | Preparation method of 2-monofluoromethylquinoline and derivatives thereof | 济南大学 | 2025-02-28 | — | — | CN | disclosed |
| US-20230322803-A1 | SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER | BRISTOL MYERS SQUIBB CO (US) | 2023-10-12 | — | — | US | disclosed |
| EP-3269789-B1 | LIGHT EMITTING MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2023-08-30 | — | — | EP | disclosed |
| US-11731994-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-20230233689-A1 | Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins | UNIV YALE (US) | 2023-07-27 | — | — | US | disclosed |
| CN-1282735-A | Amphiphili 8-hydroxyquinoline complex, its preparing process and its application in electroluminescence | UNIV JINAN (CN) | 2001-02-07 | — | — | CN | disclosed |
| EP-0952832-A1 | QUINOLINE CARBOXAMIDES AS TNF INHIBITORS AND AS PDE-IV INHIBITORS | Darwin Discovery Limited (GB) | 1999-11-03 | — | — | EP | disclosed |
| US-5804588-A | TREATING DISEASES THAT ARE MODULATED BY INHIBITION OF PHOSPHODIESTERASE IV OR TUMOUR NECROSIS FACTOR | CHIROSCIENCE LIMITED (GB) | 1998-09-08 | — | — | US | disclosed |
| WO-1997044036-A1 | QUINOLINE CARBOXAMIDES AS TNF INHIBITORS AND AS PDE-IV INHIBITORS | DARWIN DISCOVERY LIMITED (GB) | 1997-11-27 | — | — | WO | disclosed |
| EP-0480276-A2 | Carbonylaminostyrene derivatives as recording material | BAYER AG (DE) | 1992-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11731994-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | CYBA, CYC1, C1S | MCHR1 2152/4885MEN1 44/4885KMT2A 2721/4885 |
| US-20230322803-A1 | SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER | DDX21, HRAS, RPL17 | MCHR1 4218/4885MEN1 717/4885KMT2A 1071/4885 |
| US-20230233689-A1 | Bifunctional Small Molecules to Target the Selective Degradation of Circulating Proteins | ASGR1, LDLR, FCGR2A | MCHR1 976/4885MEN1 4131/4885KMT2A 3629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.